Book Review: The Philadelphia Chromosome | Books & Authors | Hudson Valley | Hudson Valley; Chronogram
Pin It
Favorite

Book Review: The Philadelphia Chromosome 

click to enlarge The Philadelphia Chromosome, Jessica Wapner, Experiment Publishing, 2013, $25.95
  • The Philadelphia Chromosome, Jessica Wapner, Experiment Publishing, 2013, $25.95

On par with the discovery of penicillin and development of antibiotics over a half century ago, the most revolutionary advance in medicine in recent times has been the advent of a pill that fights cancer at the genetic level and stops it at its root. A mention of cancer evokes a pang of dread. Treatments have often been as horrific as the disease, and its cure has long been a holy grail of science. In 2001, a drug called Gleevec was approved by the FDA after clinical trials proved miraculous against one of the direst cancers, chronic myeloid leukemia (CML)—30 out of 31 patients had their white blood cell count return to normal, and the ravaging of their bodies reversed.

The Philadelphia Chromosome, by Beacon resident Jessica Wapner, is the story of this cure. The starting point is the University of Pennsylvania in 1959, where two scientists—stumbling onto a way of enhancing the visibility of leukemia cell samples by rinsing them in tap water during slide preparation—observed an abnormally short chromosome in CML. They photographed the chromosome and published a 300-word article on their discovery. It would be decades before the notion that cancer is genetic took hold, but there were pioneering researchers who picked up the trail that the truncated Philadelphia chromosome pointed to. Improved techniques for looking at cells, such as the use of fluorescent dyes to create colorful banding patterns, enabled a University of Chicago scientist, Janet Rowley, to notice in 1973 that CML had not only a short chromosome, but also a long one; that a mysterious swap of DNA had occurred, a migration from one chromosome to another. Rowley then found "translocations" in two other cancers, thus establishing the causal link to genetic mutation.

Though interesting that a landmark discovery in cancer research was made by a woman in the same year that tennis pro Billie Jean King became a women's lib icon, unsung heroism in contemporary science is a matter of course. The author explains the progress toward Gleevec as being "like a hundred painters applying brushes to a canvas at one time or another over twenty-five years, driven only by curiosity, and sometimes, a vague hope that their work may be relevant to human cancer." An empathetic oncologist, Brian Drucker, was so dismayed by the failure of treatments that he switched his focus to oncogene research and ended up doing the most to develop this drug.

The plot to invent Gleevec, which stops a trigger in a cell (a phosphate-toting enzyme called a kinase), emerged at a time when biotech breakthroughs such as cloning and synthetic insulin were entering the subcellular arena. Wapner familiarizes readers with molecular biology, taking care not to mire the non-scientist in a swamp of acronyms. The compound ATP (adenosine triphosphate) might seem in her rendering to have a dab of personality, a scrappy character in a suspenseful drama rather than a structure diagram in a textbook. The very process of medicine by what is termed "rational design"—a targeted microengineering of mechanisms, instead of trial and error—is the paradigm shift Wapner's reporting covers.

Nowadays, pharmaceutical companies and academia are forced to collaborate, because scientists doing cutting-edge genetics are spread throughout both camps. Corporations would rather spend on marketing existing products, and shy away from paths of inquiry that are not certain to yield profits. The macroeconomics of health is certainly problematic. But Gleevec, made by Novartis, is a triumph for our species.

Speaking of...

  • Nightlife Highlights: Rock the Nest
  • Nightlife Highlights: Rock the Nest

    Rock the Nest is a four-band benefit festival to raise funds for a cure for cancer.
    • Sep 1, 2017
  • Cancer for September 2017
  • Cancer for September 2017

    It doesn't matter if you don't consider yourself a professional writer; devote yourself to learning how to express yourself in written language, and to do so well.
    • Sep 1, 2017
  • Cancer for August 2017
  • Cancer for August 2017

    You are in the process of becoming a financial ninja. See if you can set aside all the mysticism associated with money, and the emotional baggage.
    • Aug 1, 2017
  • More »
Pin It
Favorite

Comments

Subscribe to this thread:

Add a comment

Readers also liked…

  • Poetry Roundup 2016

    A selection of new books by Hudson Valley poets and presses.
    • Apr 1, 2016
  • Book Review: What Remains of Me

    Jana Martin reviews Alison Gaylin's new book.
    • Mar 1, 2016

Hudson Valley Events

submit event
Giant Tag Sale to Benefit Hudson Chorale @ Private Residence

Giant Tag Sale to Benefit Hudson Chorale

Fri., Sept. 22, 9 a.m.-4 p.m. and Sat., Sept. 23, 9 a.m.-4 p.m. — We receive both used and new donated items in a wide variety...
Dancing On The Edge: Isadora Duncan in Russia @ McKenna Theatre

Dancing On The Edge: Isadora Duncan in Russia

Fri., Sept. 22, 7:30-9:30 p.m. and Sat., Sept. 23, 7:30-9:30 p.m. — Raised in New Paltz, actor-director and theater professor Lisa Channer returns to...

View all of today's events

Latest in Books & Authors

More by Marx Dorrity

  • Short Takes

    April is National Poetry Month. A curated selection of collections by regional poets, reviewed by Marx Dorrity.
    • Apr 1, 2017
  • More »

Hudson Valley Tweets